Testagen

It's like a key labelled 'front door' that has only ever been tried in a chicken coop and a filing cabinet. Nobody has actually tried it in the front door.

Testagen is the tetrapeptide Lys-Glu-Asp-Gly (KEDG). The claimed mechanism is the generic Khavinson 'bioregulator' model: a short peptide enters cells and the nucleus and binds DNA and histones to switch tissue-specific genes on or off, here supposedly genes for testicular function. The only direct evidence is that a labelled version entered the nucleus of cultured human cancer cells and bound DNA fragments in a test tube. No study has shown any effect on testicular cells, testosterone production or sperm. In chickens the same chain was studied as a pituitary-derived peptide and affected the thyroid and thymus, which does not tell us anything about the testes.

Research contexts. Not proven uses, and not recommendations.

None. We found no study of any kind giving Testagen to people, and no study of it on testes, testosterone, sperm or fertility in animals either. The only human-derived material is a cervical cancer cell line (HeLa) used to show the peptide can enter cells in a dish. Claims that it raises testosterone, supports fertility or slows male ageing are not based on any published evidence we could find.

• !No evidence at all for its marketed purpose: no study on testes, testosterone or sperm in any species.
• !The 'testes' label exists only in the originating group's summary tables; the only animal work frames the same molecule as a pituitary peptide.
• !No human safety data of any kind.
• !Sold in the UK as an unlicensed grey-market 'research' peptide labelled not for human use; no identity, purity, sterility or endotoxin guarantees.
• !Symptoms people buy it for (low energy, low libido, fertility worries) can have treatable medical causes that self-treatment may delay finding.
• !The proposed 'peptide enters the nucleus and directly regulates genes' mechanism is contested and not well established outside the originating group.

Testagen is not a licensed medicine in the UK and holds no MHRA marketing authorisation. It is not an approved or recognised treatment for low testosterone, infertility or anything else, and we found no UK clinical trials of it. In practice it is sold online by 'research peptide' sites as a freeze-dried powder in vials, labelled for research only and not for human consumption. Selling or supplying it for human use would engage the Human Medicines Regulations 2012, and a UK clinician cannot prescribe it as a recognised therapy. Licensed testosterone treatment in the UK goes through a doctor.

• · N/A· None found

  No human or testes-related studies of Testagen (KEDG) identified

  PubMed and Europe PMC searches found no human study and no animal study of Testagen on testes, testosterone or sperm.

1. 01
   Peptide Regulation of Gene Expression: A Systematic Review — Khavinson VK, Popovich IG, Linkova NS, Mironova ES, Ilina AR, Molecules (2021)

   Originating group's review; its table lists 'KEDG, Testagen' for 'regulation of male reproductive system function'. Used for the name-to-sequence match. We found no testes study behind this assignment.

2. 02
   Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA — Fedoreyeva LI, Kireev II, Khavinson VKh, Vanyushin BF, Biochemistry (Moscow) (2011)

   Names testagen as Lys-Glu-Asp-Gly; shows uptake into the nucleus of HeLa cells and DNA-fragment binding in a test tube. Lab data, not about the testes.

3. 03
   Effect of tetrapeptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on the structure and function of the thyroid gland in neonatally hypophysectomized chickens — Kuznik BI, Pateyuk AV, Rusaeva NS, Bulletin of Experimental Biology and Medicine (2008)

   Chicken study describing Lys-Glu-Asp-Gly as synthesised from pituitary cytomedins; raised thyroid-stimulating and thyroid hormones after pituitary removal. Animal data on the same molecule, framed as pituitary-derived.

4. 04
   Effect of peptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on the morphology of the thymus in hypophysectomized young and old birds — Pateyk AV, Baranchugova LM, Rusaeva NS, Obydenko VI, Kuznik BI, Bulletin of Experimental Biology and Medicine (2013)

   Same Chita group: KEDG, described as an anterior-pituitary peptide, helped restore thymus structure in birds after pituitary removal. Animal data.

5. 05
   Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers — Khavinson V, Linkova N, Kozhevnikova E, Dyatlova A, Petukhov M, International Journal of Molecular Sciences (2022)

   Originating group's modelling paper; table lists 'Testagen (KEDG), regulator of the male reproductive system'. Computer modelling only.

6. 06
   The Inhibitory Effect and Adsorption Properties of Testagen Peptide on Copper Surfaces in Saline Environments: An Experimental and Computational Study — Dobrițescu A, Samide A, Cioateră N, et al., Molecules (2025)

   Chemistry paper testing KEDG as a copper corrosion inhibitor. Cited to show how little of the Testagen literature is biological, let alone about the testes.